Hospital
NYU Langone Hospitals
NYU Langone Hospitals was paid $2.85M by Medicaid between Jan 2018 and Oct 2024, across 163 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 11% of everything it billed.
33Billing provider infoNYU LANGONE HOSPITALS
MINEOLA, NY 11501
MINEOLA, NY 11501
33aNPI1114925567assigned 07/11/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.85M
24GClaims65,403
24DCodes billed163
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#103 of 231
Median peer was paid$561K
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,185 | $1.77M | |
| 2019 | 20,775 | $895K | |
| 2020 | 1,090 | $59K | |
| 2021 | 906 | $48K | |
| 2022 | 561 | $52K | |
| 2023 | 549 | $12K | |
| 2024incomplete | 337 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 2,577 | 2,035 | $325K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.4% | 1,232 | 1,182 | $240K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.4% | 1,635 | 1,564 | $240K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.8% | 1,106 | 1,102 | $164K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.7% | 1,107 | 1,067 | $163K |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.7% | 552 | 528 | $162K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.1% | 2,940 | 2,910 | $117K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 3.9% | 1,544 | 743 | $111K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.7% | 539 | 518 | $105K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.9% | 326 | 302 | $82K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.4% | 455 | 454 | $67K |
| T1030 | Nursing care, in the home, by registered nurse, per diem | 2.2% | 361 | 111 | $63K |
151 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 187 | $52K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.7% | 205 | $49K |
| 92552 | 1.7% | 716 | $48K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.5% | 158 | $42K |
| D1110 | Prophylaxis - adult | 1.4% | 1,010 | $40K |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.2% | 224 | $34K |
| 99173 | 1.2% | 520 | $33K | |
| G0378 | Hospital observation service, per hour | 1.1% | 164 | $33K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 1,588 | $33K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 115 | $32K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.0% | 203 | $29K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 830 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 414 | $26K |
| 99285 | Emergency room visit (most serious) | <1% | 148 | $25K |
| 99177 | <1% | 276 | $24K | |
| D0120 | Dental checkup, returning patient | <1% | 1,071 | $23K |
| 80053 | Comprehensive metabolic panel | <1% | 683 | $23K |
| 80076 | <1% | 784 | $23K | |
| D1120 | Dental cleaning, child | <1% | 537 | $18K |
| 86901 | <1% | 554 | $18K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 102 | $18K |
| 86900 | <1% | 554 | $18K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 102 | $17K |
| 93975 | <1% | 34 | $15K | |
| J3490 | Unclassified drugs | <1% | 675 | $14K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 32 | $13K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 178 | $12K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 315 | $11K |
| 99174 | <1% | 185 | $11K | |
| 96415 | <1% | 13 | $11K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 79 | $10K |
| 86850 | <1% | 547 | $10K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 228 | $10K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 357 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,215 | $9K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 347 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,302 | $8K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 54 | $8K |
| 87486 | <1% | 347 | $7K | |
| 87581 | <1% | 347 | $7K | |
| 86780 | <1% | 219 | $7K | |
| 83655 | <1% | 436 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 753 | $6K |
| G0379 | Direct admission of patient for hospital observation care | <1% | 125 | $6K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 40 | $6K |
| D0274 | Bitewings - four radiographic images | <1% | 277 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 587 | $5K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 559 | $5K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 199 | $5K |
| 81025 | <1% | 1,178 | $5K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $5K |
| D0140 | Limited oral evaluation - problem focused | <1% | 409 | $4K |
| D1206 | Topical application of fluoride varnish | <1% | 226 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 121 | $4K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 23 | $3K |
| 59025 | Fetal non-stress test | <1% | 16 | $3K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 493 | $3K |
| 87040 | <1% | 248 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 343 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 627 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 315 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,266 | $2K |
| 88142 | <1% | 66 | $2K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 216 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 14 | $2K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 14 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 331 | $2K |
| 80061 | Lipid panel | <1% | 125 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 470 | $2K |
| 81001 | <1% | 1,545 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 700 | $2K |
| 84702 | <1% | 232 | $2K | |
| 86701 | <1% | 155 | $2K | |
| 90670 | <1% | 1,113 | $1K | |
| 90647 | <1% | 1,104 | $1K | |
| 90686 | <1% | 765 | $1K | |
| 90723 | <1% | 864 | $982.67 | |
| 87510 | <1% | 31 | $951.52 | |
| 90633 | <1% | 528 | $929.10 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 55 | $929.09 |
| 90715 | <1% | 87 | $884.05 | |
| D0272 | Bitewings - two radiographic images | <1% | 69 | $883.54 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 13 | $873.12 |
| 90651 | <1% | 125 | $833.89 | |
| 90680 | <1% | 816 | $823.80 | |
| 85610 | <1% | 530 | $819.45 | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 14 | $805.90 |
| 90685 | <1% | 632 | $786.29 | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 29 | $785.40 |
| 87660 | <1% | 31 | $779.17 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 168 | $758.78 |
| 84439 | <1% | 139 | $709.57 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 226 | $697.27 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 108 | $643.55 |
| 80069 | <1% | 36 | $627.09 | |
| 84484 | <1% | 385 | $570.95 | |
| 83690 | <1% | 614 | $551.28 | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 39 | $542.95 |
| 87081 | <1% | 327 | $542.23 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 318 | $521.04 |
| 88342 | <1% | 24 | $514.66 | |
| 82150 | <1% | 474 | $491.54 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $485.06 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 12 | $461.38 |
| 85027 | <1% | 80 | $455.18 | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 14 | $444.50 |
| 85730 | <1% | 507 | $441.48 | |
| 83735 | <1% | 403 | $418.05 | |
| 90716 | <1% | 197 | $393.59 | |
| 90707 | <1% | 178 | $357.89 | |
| 81002 | <1% | 497 | $336.01 | |
| 82550 | <1% | 287 | $321.01 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 26 | $309.32 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 18 | $309.01 |
| 90700 | <1% | 210 | $293.81 | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 46 | $274.50 |
| 87340 | <1% | 56 | $248.99 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 107 | $224.15 |
| 87480 | <1% | 31 | $224.11 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 312 | $189.13 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 85 | $184.66 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 738 | $173.44 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 385 | $158.22 |
| 86140 | <1% | 155 | $152.95 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 494 | $151.66 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 377 | $145.22 |
| 90696 | <1% | 72 | $107.99 | |
| 90710 | <1% | 84 | $107.99 | |
| 90734 | <1% | 55 | $107.10 | |
| 85652 | <1% | 131 | $79.40 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 100 | $78.56 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 289 | $77.30 |
| 73610 | <1% | 14 | $75.10 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 390 | $46.70 |
| 82728 | <1% | 16 | $44.25 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 78 | $41.97 |
| 83540 | <1% | 35 | $40.24 | |
| 82248 | <1% | 29 | $38.91 | |
| 83550 | <1% | 31 | $35.21 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 208 | $18.88 |
| 84550 | <1% | 22 | $15.09 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 12 | $14.63 |
| 84100 | <1% | 42 | $10.06 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 243 | $5.40 |
| 83615 | <1% | 20 | $5.03 | |
| 71045 | Radiologic examination, chest; single view | <1% | 22 | $4.31 |
| 36416 | 0% | 68 | $0.00 | |
| 83605 | 0% | 14 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 32 | $0.00 |
| 99080 | 0% | 376 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCATALIOTTI, PALMIRA (SVP & CFO)
| Provider | Location | Paid |
|---|---|---|
| NYU Langone Hospitals | Mineola, NY | $2.80M |
| NYU Langone Hospitals | Mineola, NY | $2.50M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.